SCHEMBL1664624

SCHEMBL1664624

Cn1ccc(C(=O)Nc2ccc(Nc3ccc(Nc4ccc(N5CCC(O)CC5)cc4)cc3)c(C#N)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
MAPT P10636 5/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
HPGD P15428 3/20 0.46
HSD17B10 Q99714 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
RXFP1 Q9HBX9 2/20 0.46
TBK1 Q9UHD2 3/20 0.41
JAK2 O60674 2/20 0.41
KDM4E B2RXH2 1/20 0.40
PDE7A Q13946 1/20 0.39
HPGDS O60760 1/20 0.38
EGFR P00533 2/20 0.37
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
USP2 O75604 2/20 0.37
ALOX15 P16050 1/20 0.37
ABL1 P00519 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664163 0.97 SMN1; SMN2 (0.44) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL1664167 0.96 MAPT (0.49) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL1664626 0.96 MAPT (0.49) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL17072271 0.90 KMT2A (0.47) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL1665596 0.88 MAPT (0.54) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL1664809 0.87 EGFR (0.42) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL1665848 0.87 PDE7A (0.40) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL21254565 0.86 MAPT (0.53) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL1664139 0.85 ALDH1A1 (0.44) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL1662766 0.84 RAB9A (0.51) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed